IFNB1 and multiple sclerosis: During last years, several drugs have been approved for the treatment of multiple sclerosis (MS), nonetheless, interferon beta (IFNβ) continues being a widely used treatment for newly diagnosed patients with relapsing-onset multiple sclerosis.